Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action

Author:

Steinman Jonathan B1ORCID,Santarossa Cristina C1,Miller Rand M1,Yu Lola S1,Serpinskaya Anna S2,Furukawa Hideki3,Morimoto Sachie3,Tanaka Yuta3,Nishitani Mitsuyoshi4,Asano Moriteru3,Zalyte Ruta5,Ondrus Alison E6,Johnson Alex G7,Ye Fan8,Nachury Maxence V8,Fukase Yoshiyuki3,Aso Kazuyoshi3,Foley Michael A3,Gelfand Vladimir I2,Chen James K7,Carter Andrew P5,Kapoor Tarun M1ORCID

Affiliation:

1. Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States

2. Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, United States

3. Tri-Institutitional Therapeutics Discovery Institute, New York, United States

4. Pharmaceutical Research Division, Takeda Pharmaceuticals Ltd, Kanagawa, Japan

5. Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom

6. Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States

7. Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States

8. Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States

Abstract

Cytoplasmic dyneins are motor proteins in the AAA+ superfamily that transport cellular cargos toward microtubule minus-ends. Recently, ciliobrevins were reported as selective cell-permeable inhibitors of cytoplasmic dyneins. As is often true for first-in-class inhibitors, the use of ciliobrevins has in part been limited by low potency. Moreover, suboptimal chemical properties, such as the potential to isomerize, have hindered efforts to improve ciliobrevins. Here, we characterized the structure of ciliobrevins and designed conformationally constrained isosteres. These studies identified dynapyrazoles, inhibitors more potent than ciliobrevins. At single-digit micromolar concentrations dynapyrazoles block intraflagellar transport in the cilium and lysosome motility in the cytoplasm, processes that depend on cytoplasmic dyneins. Further, we find that while ciliobrevins inhibit both dynein's microtubule-stimulated and basal ATPase activity, dynapyrazoles strongly block only microtubule-stimulated activity. Together, our studies suggest that chemical-structure-based analyses can lead to inhibitors with improved properties and distinct modes of inhibition.

Funder

National Institutes of Health

Robertson Therapeutic Development Fund

Damon Runyon Cancer Research Foundation

Medical Research Council

Wellcome

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference68 articles.

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3